Today: 20 May 2026
ICL stock today: ICL Group ends 2025 up 3% as China potash contracts shape the 2026 view
1 January 2026
2 mins read

ICL stock today: ICL Group ends 2025 up 3% as China potash contracts shape the 2026 view

NEW YORK, January 1, 2026, 10:34 ET — Market closed

ICL Group Ltd (NYSE: ICL) shares last closed up 3.0% at $5.71 on Wednesday. U.S. stock markets were shut on Thursday for New Year’s Day, according to the .

The move matters heading into 2026 because ICL’s earnings are closely tied to crop-nutrient pricing, especially potash and phosphate fertilizers. Those prices can swing quickly as buyers in big markets lock in supply and farmers respond to crop economics.

Potash pricing is in focus after a late-December filing in which ICL said it signed contracts to supply 750,000 metric tons of potash to customers in China during 2026, with a mutual option for another 330,000. The contracts were priced in line with recent China settlements at $348 per ton on a CIFFO basis, the filing showed.

CIFFO is a delivered-price term that includes freight, insurance and unloading at the destination port. China’s contract settlements often act as a reference point for broader potash negotiations because they can influence pricing talks in other regions.

On the demand side, retail fertilizer prices tracked by were mostly lower in the fourth week of December, led by a 6% month-on-month drop in diammonium phosphate, or DAP, to $866 a ton. DTN pegged monoammonium phosphate (MAP) at $884 and potash at $484, while urea averaged $567.

Even with the late-month dip, DTN said all eight products it tracks were higher than a year earlier, including potash up 9% and DAP up 17%. For producers, that mix can support revenue but also tests how much growers will pay before cutting application rates.

That backdrop links ICL to a broader group of fertilizer names that traders use as read-throughs on nutrient pricing, including Nutrien and Mosaic in potash and phosphate, and CF Industries in nitrogen.

Macro conditions remain a swing factor. The World Bank said in an October outlook that global commodity prices are projected to fall again in 2026 as growth stays weak and oil supply rises, a setup that can ripple into crop input markets.

ICL has also been pitching a strategy that leans on higher-margin specialty lines alongside its commodity exposure. “ICL delivered solid year-over-year growth in both sales and EBITDA,” Chief Executive Elad Aharonson said in a November quarterly statement, where the company reiterated a 2025 specialties-driven adjusted EBITDA outlook of $0.95 billion to $1.15 billion and potash sales volume of 4.3 million to 4.5 million metric tons. Q4 Capital

In the last session, ICL traded between $5.53 and $5.76 and sits within a 52-week range of $4.85 to $7.35, according to . Volume was about 1.86 million shares versus an average daily volume of about 858,000.

Before Friday’s reopening, traders will watch for early-January signals on fertilizer affordability and demand. The World Bank’s next commodity price update is due Jan. 6, and the USDA’s next WASDE report is scheduled for Jan. 12.

On the company calendar, earnings trackers such as list ICL’s next report date as Feb. 25, though schedules can change. Investors will be looking for potash realized pricing versus contracted levels in China, and for any update on volumes under the 2026 agreements.

Stock Market Today

  • Roivant Sciences Q4 Loss Beats Estimates; Revenue Misses
    May 20, 2026, 9:59 AM EDT. Roivant Sciences Ltd. reported a fourth-quarter loss of $0.23 per share, better than the Zacks estimate of a $0.25 loss, marking an 8% positive earnings surprise. Revenue missed expectations, coming in at $28.93 million, down 11% from estimates but up from $27.38 million a year ago. Despite three out of four quarters beating EPS estimates recently, the company's shares have declined 4.5% year-to-date, underperforming the S&P 500's 10.4% rise. Earnings outlook remains cautious with a Zacks Rank #4 (Sell), suggesting expected near-term underperformance. Current consensus projects a loss of $0.21 per share next quarter on $56.64 million revenue and a fiscal year loss of $1.07 on $172.45 million. Industry outlook in medical-biomedical genetics also weighs on investor sentiment.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Previous Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Gold price forecast for 2026: Banks map a $4,275-$5,000 range after bullion’s blockbuster year
Next Story

Gold price forecast for 2026: Banks map a $4,275-$5,000 range after bullion’s blockbuster year

Go toTop